Decheng Capital Global Life Sciences Fund IV L.P. 13D and 13G filings for Equillium, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 5:21 pm Purchase | 2021-02-05 | 13D | Equillium, Inc. EQ | Decheng Capital Global Life Sciences Fund IV L.P. | 5,733,021 19.700% | 5,733,021 (New Position) | Filing |